Diagnosing Deep-vein Thrombosis Early in Critically Ill Patients
Recruiting
N/A
Interventional Study
Deep Vein Thrombosis
Pulmonary Embolism
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 1,800 (estimated)
- Sponsor
- King Abdullah International Medical Research Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The DETECT randomized controlled trial addresses the question of whether surveillance ultrasound in critically ill patients by facilitating DVT detection reduces the incidence of PE and lowers all-cause 90-day mortality. The primary outcome is 90-day all-cause mortality.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
1. Medical, surgical or trauma ICU patients ≥18 years old.
2. Patients who are expected to stay in the ICU more than 2 calendar days (unlikely to be discharged out of ICU on the day of admission or on the next day).
Exclusion Criteria
1. Patients with DVT or PE diagnosed within…
Contacts